Roche – drop the price of trastuzumab!

On Tuesday, 7th February 2017, Swiss multinational company Roche faced global condemnation from women living with cancer, families of people with cancer, activists, scientists, researchers and health professionals from across the world. They highlighted the immoral and unconscionable tactics employed by Roche across the developed and developing world. Roche’s greed is preventing women from accessing affordable versions of trastuzumab, an essential medicine used in the treatment of breast cancer. #ForTobeka #RocheGreedKills

Related Articles